山东大学学报 (医学版) ›› 2023, Vol. 61 ›› Issue (11): 111-115.doi: 10.6040/j.issn.1671-7554.0.2023.0938
• 病例报道 • 上一篇
李昱呈1,王敏2,王春花2,陈俞洁2
中图分类号:
| [1] Chaker L, Razvi S, Bensenor IM, et al. Hypothyroidism[J]. Nat Rev Dis Primers, 2022, 8(1): 30. [2] 何健. 桥本甲状腺炎临床诊断的现状与进展[J]. 标记免疫分析与临床, 2022, 29(11): 1961-1966. HE Jian.An Exploration study of clinical diagnosis and treatment of Hashimotos thyroiditis[J]. Labeled Immunoassays and Clinical Medicine, 2022, 29(11): 1961-1966. [3] Smith TJ, Hegedüs L. Graves Disease[J]. N Engl J Med, 2016, 375(16): 1552-1565. [4] Vargas-Uricoechea H. Molecular mechanisms in autoimmune thyroid disease[J]. Cells, 2023, 12(6): 918. [5] Klubo-Gwiezdzinska J, Wartofsky L. Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment[J]. Pol Arch Intern Med, 2022, 132(3): 16222. [6] Walsh JP, Bremner AP, Feddema P, et al. Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques[J]. J Clin Endocrinol Metab, 2010, 95(3): 1095-1104. [7] Ehlers M, Thiel A, Bernecker C, et al. Evidence of a combined cytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimotos thyroiditis[J]. J Clin Endocrinol Metab, 2012, 97(4): 1347-1354. [8] Mcleod DS, Cooper DS, Ladenson PW, et al. Race/Ethnicity and the prevalence of thyrotoxicosis in young Americans[J]. Thyroid, 2015, 25(6): 621-628. [9] Jacobson EM, Huber A, Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology[J]. J Autoimmun, 2008, 30(1-2): 58-62. [10] Zhao SX, Xue LQ, Liu W, et al. Robust evidence for five new Graves disease risk loci from a staged genome-wide association analysis[J]. Hum Mol Genet, 2013, 22(16): 3347-3362. [11] Huang CY, Chang TY, Chu CC, et al. The HLA-B gene and Hashimoto disease in Han Chinese children: a case-control and family-based study[J]. Tissue Antigens, 2012, 80(5): 431-436. [12] Inoue N, Watanabe M, Morita M, et al. Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases[J]. Clin Exp Immunol, 2010, 162(3): 402-406. [13] Chistiakov DA, Chistiakova EI, Voronova NV, et al. A variant of the Il2ra/Cd25 gene predisposing to graves disease is associated with increased levels of soluble interleukin-2 receptor[J]. Scand J Immunol, 2011, 74(5): 496-501. [14] Piantanida E, Ippolito S, Gallo D, et al. The interplay between thyroid and liver: implications for clinical practice[J]. J Endocrinol Invest, 2020, 43(7): 885-899. [15] Mantovani A, Nascimbeni F, Lonardo A, et al. Association between primary hypothyroidism and nonalcoholic fatty liver disease: a systematic review and meta-analysis[J]. Thyroid, 2018, 28(10): 1270-1284. [16] Xiao XH, Qi XY, Li JY, et al. Serum zinc-α2-glycoprotein levels are elevated and correlated with thyroid hormone in newly diagnosed hyperthyroidism[J]. BMC Endocr Disord, 2019, 19(1): 12. [17] Martínez-Sánchez N, Seoane-Collazo P, Contreras C, et al. Hypothalamic AMPK-ER stress-JNK1 axis mediates the central actions of thyroid hormones on energy balance[J]. Cell Metab, 2017, 26(1): 212-229. [18] 苏晓慧, 李维辛. 促甲状腺激素甲状腺外作用的研究进展[J]. 山东医药, 2018, 58(46): 101-104. SU Xiaohui, LI Weixin. Research progress on extrathyroidal effects of thyrotropin[J]. Shandong Medical Journal, 2018, 58(46): 101-104. [19] Tian L, Song Y, Xing M, et al. A novel role for thyroid-stimulating hormone: up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase expression through the cyclic adenosine monophosphate/protein kinase A/cyclic adenosine monophosphate-responsive element binding protein pathway[J]. Hepatology, 2010, 52(4): 1401-1409. [20] Papatheodoridi M, Cholongitas E. Diagnosis of non-alcoholic fatty liver disease(NAFLD): current concepts[J]. Curr Pharm Des, 2018, 24(38): 4574-4586. [21] Efstathiadou ZA, Kita MD, Polyzos SA. Thyroid dysfunction and non-alcoholic fatty liver disease[J]. Minerva Endocrinol, 2018, 43(3): 367-376. [22] Musso G, Cassader M, Paschetta E, et al. Bioactive lipid species and metabolic pathways in progression and resolution of nonalcoholic steatohepatitis[J]. Gastroenterology, 2018, 155(2): 282-302. [23] Al-Janabi G, Hassan HN, Al-Fahham A. Biochemical changes in patients during hypothyroid phase after thyroidectomy[J]. J Med Life, 2022, 15(1): 104-108. [24] 肖潇, 马雄. 自身免疫性肝病[J]. 肝脏, 2023, 28(1): 25-27. XIAO Xiao, MA Xiong. Autoimmune liver disease[J]. Chinese Hepatology, 2023, 28(1): 25-27. [25] Ma Y, Su H, Yuksel M, et al. Human leukocyte antigen profile predicts severity of autoimmune liver disease in children of european ancestry[J]. Hepatology, 2021, 74(4): 2032-2046. [26] Béland K, Marceau G, Labardy A, et al. Depletion of B cells induces remission of autoimmune hepatitis in mice through reduced antigen presentation and help to T cells[J]. Hepatology, 2015, 62(5): 1511-1523. [27] Wong GW, Yeong T, Lawrence D, et al. Concurrent extrahepatic autoimmunity in autoimmune hepatitis: implications for diagnosis, clinical course and long-term outcomes[J]. Liver Int, 2017, 37(3): 449-457. [28] Renous R, Lapierre P, Djilali-Saiah I, et al. Characterization of the antigenicity of the formiminotransferase-cyclodeaminase in type 2 autoimmune hepatitis[J]. Exp Cell Res, 2004, 292(2): 332-341. [29] 曹蒙, 关锐. 自身免疫性肝病抗体谱检测在自身免疫性肝病诊断中的应用价值[J]. 临床医学研究与实践, 2022, 7(17): 140-143. CAO Meng, GUAN Rui. Application value of autoimmune liver disease antibody spectrum detection in the diagnosis of autoimmune liver disease[J]. Clinical Research and Practice, 2022, 7(17): 140-143. [30] 蔡军, 王荣. 自身免疫性肝病诊断中的抗肝抗原自身抗体检测分析[J]. 山西医药杂志, 2021, 50(10): 1723-1724. CAI Jun, WANG Rong. Detection and analysis of anti-liver antigen autoantibodies in the diagnosis of autoimmune liver disease[J]. Shanxi Medical Journal, 2021, 50(10): 1723-1724. |
| [1] | 王韶卿 刘毅慧 付婷婷 成金勇 刘强. 肝癌31磷磁共振波谱数据的分类[J]. 山东大学学报(医学版), 2209, 47(6): 42-46. |
| [2] | 朱金羽,高帅,王凯. 控制营养状态评分在乙肝肝硬化中的临床价值[J]. 山东大学学报 (医学版), 2023, 61(7): 72-77. |
| [3] | 李祥泽,王先明,宋歌声,崔晶,孙凯,王皓晨,王天成,韩绍奇,田虎. 合并乙肝肝硬化的肝上皮样血管内皮瘤1例报道并文献复习[J]. 山东大学学报 (医学版), 2022, 60(11): 89-95. |
| [4] | 马玉杰,黄启坤,孙丽伟,刘艳丽. 儿童嗜酸性粒细胞性胃肠炎伴胸腹水1例并文献复习[J]. 山东大学学报 (医学版), 2021, 59(7): 125-128. |
| [5] | 石小岩,彭洪菊,孙国珍,马亮亮. 以大量腹腔积液为主要表现的POEMS综合征1例并文献复习[J]. 山东大学学报 (医学版), 2021, 59(2): 114-117. |
| [6] | 康成为,刘雷,蒲小兵,谭钢,董长超,晏兆魁. 合并亚临床型甲状腺功能减退的骨质疏松症62例患者骨代谢及骨转换标志物水平分析[J]. 山东大学学报 (医学版), 2020, 58(5): 82-86. |
| [7] | 于娜,郭情情,孙梅,盛燕,马增香,秦莹莹. 甲状腺癌术后行IVF/ICSI-ET助孕临床结局[J]. 山东大学学报 (医学版), 2018, 56(9): 54-58. |
| [8] | 丁艳菲,杨卓鑫,郑文文,袁文杰,高艳景. 肝硬化门静脉血栓形成的相关危险因素[J]. 山东大学学报 (医学版), 2018, 56(12): 13-18. |
| [9] | 张琨,张孝国,崔杏杏,陈士俊. 慢性HBV感染者外周血单个核细胞凋亡相关因子的表达及其与乙肝慢性化的关系[J]. 山东大学学报（医学版）, 2016, 54(7): 38-42. |
| [10] | 郝战宇,李波. 桥本甲状腺炎合并甲状腺乳头状癌的临床及病理学特征[J]. 山东大学学报（医学版）, 2016, 54(6): 73-77. |
| [11] | 刘彩峰, 汪明明, 李新立, 崔速南. 托伐普坦治疗肝硬化顽固性腹水并低钠血症的疗效[J]. 山东大学学报（医学版）, 2016, 54(1): 33-37. |
| [12] | 黄旻. 肝硬化上消化道出血的内科治疗方法探讨[J]. 山东大学学报（医学版）, 2014, 52(S2): 24-24. |
| [13] | 刘士锦. 肝硬化合并上消化道出血患者的观察与护理[J]. 山东大学学报（医学版）, 2014, 52(S2): 130-131. |
| [14] | 吴斌, 何文涛, 程云峰, 章以法, 吴东刚. 肝硬化患者血清高密度脂蛋白胆固醇检测的临床意义[J]. 山东大学学报（医学版）, 2014, 52(S2): 19-19. |
| [15] | 王光亚, 郭宁宁, 赵乃蕊, 李瑞杰, 高书明. 脂联素水平在2型糖尿病和甲状腺疾病中的变化及意义[J]. 山东大学学报（医学版）, 2014, 52(S1): 96-97. |
|
||
